AgencyIQ will host a follow-up to our recent COVID-19 webinar on Tuesday, April 7th, from 12:00 pm to 1:00 pm. This virtual webinar will include updated analysis of FDA policy, guidance, and announcements concerning the novel coronavirus. To attend, register using the link provided below.
- Date: Tuesday, April 7th, 12:00 pm – 1:00 pm EST
- Registration: https://zoom.us/webinar/register/WN_YruYSrUbTEuXhIiCpv17Ng
- Calendar hold: You will receive a calendar hold upon registering.
- For registration support, contact: Dayton Potter at firstname.lastname@example.org
Background: This webinar is designed to address the information needs of regulatory affairs professionals at pharmaceutical, biotechnology, in vitro diagnostic (IVD), and medical device companies, who are on the front lines of combating the unprecedented public health crisis posed by the novel coronavirus. AgencyIQ will assess how regulatory affairs professionals can navigate rapidly-evolving FDA policy and guidance to get products to test for, treat, and vaccinate against COVID-19 to the public.